Algorithmiq
Algorithmiq develops algorithms to solve currently inaccessible problems in life sciences. The company utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
Algorithmiq
Algorithmiq develops algorithms to solve currently inaccessible problems in life sciences. The company utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
TL;DR
HQ: Helsinki, Finland
Focus: Quantum algorithms, error mitigation, and quantum chemistry for life sciences and materials
Founded: 2020
Employees: 46
Known investors: Tiger Global, K5 Global, Inventure
Total disclosed funding: USD 19,340,000 (as of 2023-06-27)
Company Overview
Problem Domain
Drug discovery, life sciences, and materials science computational problems
Founded
2020
Industry
Quantum software / Quantum computing
Tech Stack
Funding Track Record
USD 4,000,000
Seed round included Tiger Global, K5 Global and angel investors
Investor Signal
“Participation from Tiger Global, K5 Global, Inventure and multiple angels”